View: Immediate Halting of Bleeding with Rapid Application of Band-Aid Gel
A groundbreaking medical adhesive called VetiGel, developed by U.S. biotech company Suneris, may transform the way severe wounds and deep cuts are treated. Made from plant-based polymers, VetiGel is designed to activate the body's natural clotting process almost instantly, sealing wounds within seconds.
Blood platelets rapidly bind together to form a stable clot, negating the need for external pressure and leaving the gel to be absorbed into the body without causing harm. With potential applications in emergency medical kits, military field operations, and household first aid, VetiGel could mean the difference between life and death.
In an accident or emergencies, paramedics, soldiers, or even bystanders could use VetiGel to stop bleeding almost instantly, reducing the risk of excessive blood loss before proper medical care is available. The gel is the brainchild of Joe Landolina, who created it during his time at New York University.
The gel works by triggering the rapid production of fibrin, the protein responsible for blood clotting. The plant-derived polymers reassemble on contact with damaged tissue, acting as a biological scaffold to facilitate the body's natural repair process. Unlike conventional clotting agents, VetiGel does not require external pressure or chemical activation.
The potential use of VetiGel in emergency medicine shows its impact, particularly in situations where traditional first aid may not be enough, such as severe car accidents or deep knife wounds. In these cases, paramedics could instantly apply the gel to control bleeding, thereby reducing the risk of excessive blood loss before the patient reaches the hospital.
In combat situations, rapid blood loss remains a leading cause of preventable deaths. If every soldier carried VetiGel in their medical kit, survival rates could dramatically improve. The gel challenges the conventional wisdom that controlling heavy bleeding requires stitches or traditional bandaging techniques.
As with any groundbreaking medical innovation, preliminary tests indicate positive results, but critics argue that large-scale human trials are still necessary to confirm its effectiveness. VetiGel has already shown impressive results in veterinary medicine, where it is undergoing testing in animal hospitals.
Suneris is working closely with regulatory bodies to ensure VetiGel meets all safety and efficacy standards, with the intention of making it available in every ambulance, soldier's kit, and even households. The potential for rapid approval processes, especially in military and emergency settings, is high as it could immediately start saving lives.
As of now, VetiGel is primarily used in veterinary medicine. Its status for human applications remains in the realm of potential future applications, with regulatory hurdles to be cleared before it can be used by humans. However, Suneris is committed to making VetiGel a household name, potentially changing the landscape of wound care forever.
Sources: Suneris, Bloomberg News, SPLoid
This innovative adhesive, VetiGel, developed by Suneris, could revolutionize the field of health-and-wellness, particularly in treating medical-conditions like severe wounds and deep cuts. By activating the body's natural clotting process, VetiGel leverages both technology and science to provide therapies-and-treatments that bypass traditional methods, potentially saving lives in emergencies.
